Immediate Impact
49 standout
Citing Papers
Vanzacaftor–tezacaftor–deutivacaftor for children aged 6–11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
2025 Standout
Lung microbiome: new insights into the pathogenesis of respiratory diseases
2024 Standout
Works of Isabelle Danner‐Boucher being referenced
Sustained effectiveness of elexacaftor-tezacaftor-ivacaftor in lung transplant candidates with cystic fibrosis
2022
Disseminated Scedosporium / Pseudallescheria Infection after Double-Lung Transplantation in Patients with Cystic Fibrosis
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Isabelle Danner‐Boucher | 172 | 171 | 65 | 214 | 20 | 406 | |
| Grzegorz Kofla | 48 | 163 | 95 | 205 | 21 | 457 | |
| Mary S. Mathews | 24 | 201 | 56 | 189 | 23 | 449 | |
| Katie Dunne | 103 | 90 | 55 | 198 | 15 | 442 | |
| J.L. Yntema | 141 | 109 | 56 | 108 | 20 | 378 | |
| Katharina Seeber | 45 | 333 | 27 | 324 | 18 | 445 | |
| Kenneth J. Hammerman | 76 | 229 | 22 | 226 | 14 | 372 | |
| Charles A. Brasher | 47 | 325 | 53 | 250 | 19 | 431 | |
| Shuying Li | 77 | 180 | 70 | 171 | 28 | 449 | |
| Jackie Rendall | 243 | 74 | 19 | 129 | 16 | 360 | |
| William A. Winn | 39 | 298 | 37 | 252 | 15 | 403 |
All Works
Loading papers...